The Early Access Programmes Summit Europe returns for a second year this October, aiming to help the industry navigate the notoriously complex European regulatory landscape, and conquer operational hurdles to provide patients in Europe with early access to medicines.

This meeting provides a forum to address burning questions and share ideas on topics such as European regulatory guidelines, labelling, supply, and best practices around reimbursement, integrating of pre- and post-trial access programmes and scoping.

Providing practical, valuable case studies is this year’s expert speaker lineup including the likes of GlaxoSmithKline, Roche, Novartis, Sanofi, and many others! Visit our website to download a free copy of the full event guide to explore the jam-packed 3-day agenda and full speaker faculty.

Whether you’re a veteran at managing early access programmes and are looking to expand your geo, or a new entrant to the field, you’ll leave this conference with the practical lessons and essential connections needed to supercharge your European early access programme across 2023 and beyond.

To know more visit: https://bit.ly/3K4BpqO